Impact of activated protein C resistance on general vascular surgical patients

Journal of Vascular Surgery

Volumn 25, Issue 6, 1997, Pages 1054-1060

  Donaldson, M C ^a   Belkin, M ^a   Whittemore, A D ^a   Mannick, J A ^a   Longtine, J A ^a   Dorfman, D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5; HEPARIN; WARFARIN;

AORTA SURGERY; ARTERY RECONSTRUCTION; ARTICLE; BYPASS SURGERY; CEREBROVASCULAR DISEASE; CEREBROVASCULAR SURGERY; CONTROLLED STUDY; GENE MUTATION; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MORBIDITY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOSIS; VASCULAR SURGERY;

EID: 0030941381     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(97)70129-0     Document Type: Article

References (21)

1. JH Griffin B Evatt C Wideman JA Fernandez Anticoagulant protein C pathway defective in majority of thrombophilic patients Blood 82 1993 1989 1993
2. B Dahlback M Carlsson PJ Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci U S A 90 1993 1004 1008
3. RM Bertina BP Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
4. B Zoller B Dahlback Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536 1538
5. KA Hajjar Factor V Leiden-an unselfish gene [editorial]? N Engl J Med 331 1994 1585 1587
6. NJ Beauchamp ME Baly KK Hampton PC Cooper FE Preston IR Peake High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis Br J Haematol 88 1994 219 222
7. PM Ridker CH Hennekens K Lindpainter MJ Stampfer PR Eisenberg JP Miletich Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 332 1995 912 917
8. V DeStefano G Finazzi PM Mannucci Inherited thrombophilia: pathogenesis, clinical syndromes, and management Blood 87 1996 3531 3544
9. DR Hirsch KM Mikkola PW Marks EA Fox DM Dorfman BM Ewenstein Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden Am Heart J 131 1996 1145 1148
10. MA Montes EA Fox JA Longtine DM Dorfman Functional analysis for resistance to activated protein C (factor V R506Q) is sensitive but not specific compared with polymerase chain reaction (PCR) analysis: comparison of findings from 370 patients [abstract] Am J Clin Pathol 106 1996 402
11. RM Bertina PH Reitsma FR Rosendaal JP Vandenbroucke Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis Thromb Haemost 74 1 1995 449 453
12. MC Donaldson Hypercoagulable states in patients with peripheral vascular disease AD Whittemore Advances in vascular surgery vol. 1 1993 Mosby–Year Book, Inc St. Louis 227 242
13. PJ Svensson B Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
14. K Ouriel RM Green JA DeWeese C Cimino Activated protein C resistance: prevalence and implications in peripheral vascular disease J Vasc Surg 23 1996 46 52
15. T Koster FR Rosendaal H de Ronde E Briet JP Vandenbroucke RM Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilic study Lancet 342 1993 1503 1506
16. B Zoller PJ Svensson X He B Dahlback Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524
17. MS Makaroun DL Steed MW Webster SC Muluk RY Rhee ALC Hassett Thrombotic events in patients with factor V Leiden mutation J Vasc Surg 1997 (in press)
18. FR Rosendaal T Koster JP Vandenbroucke PH Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
19. WM Halbmayer A Haushofer R Schon M Fischer The prevalence of poor anticoagulant response to activated protein C among patients suffering from stroke or venous thrombosis and among healthy subjects Blood Coagul Fibrinolysis 5 1994 51 57
20. M Cushman F Bhushan E Bovill Plasma resistance to activated protein C in venous and arterial thrombosis [letter] Thromb Haemost 72 1994 647
21. MC Donaldson DS Weinberg M Belkin AD Whittemore JA Mannick Screening for hypercoagulable states in vascular surgical practice: a preliminary study J Vasc Surg 11 1990 825 831